Owing to the critical role of RAS in cell cycle regulation and tissue growth, the majority of studies investigating neurofibromin function have focused on its RAS-GAP properties, especially in the context of cancer, where oncogenic mutations affecting RAS signaling drive tumorigenesis. This evidence concerns the gene NF1 and cancer.